Enzon and Viskase Announce Amendment to Merger Agreement
(Other OTC:ENZN),(OTC US:ENZN),(PinkSheets:VKSC), CRANFORD, N.J. and LOMBARD, Ill., Oct. 24, 2025 (GLOBE NEWSWIRE) — Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or the “Company“) and Viskase Companies, Inc. (OTC Pink Limited: VKSC) (“Viskase“) today announced that they have entered into an amendment (the “Amendment“) to the previously disclosed Agreement and Plan of Merger (the “Merger Agreement“), […]